Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole suppositories with Yuexiao gel for bacterial vaginosis recurrence prevention
ChiCTR2600124081Phase 4Completed
- Sponsor
- Chengdu Qingbaijiang District People's Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metronidazole and Yuexiao Antibacterial Gel in bacterial vaginosis (BV) (3 arms), sponsored by Chengdu Qingbaijiang District People's Hospital. Primary endpoints: Cure rate, Overall efficiency rate and 1 more. Started May 2026; status: completed.
02
Drugs
metronidazoleYuexiao Antibacterial Gel
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ChiCTR2600124081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124081.